VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose
    Herman, Darja ...
    Warfarin is an anticoagulant drug with narrow therapeutic index and high interindividual variability in dose requirement. S-warfarin is metabolized mainly by polymorphic cytochrome P450 (CYP) 2C9. We ... systematically quantified the influence of CYP2C9 genotype, demographic factors and concomitant drug treatment on warfarin metabolism and maintenance dose. The mean warfarin doseswere lower in carriers of one (2.71 mgžday, 59 patients) and two polymorphic alleles (1.64 mgžday, 11 patients) than in carriers of two wild-type alleles (4.88 mgžday, 118 patients). Multiple regression analysis demonstrated that CYP2C9 genotype, age, concomitant treatment with warfarin metabolism inducers and lean body weight contributed significantly to interindividual variability in warfarin dose requirement (adjusted R2=0.37). The same factors, except for age, significantly influenced S-warfarin clearance (adjusted R2=0.42). These results can serve as a starting point for designing prospective studies in patients in the initiation phase of genotype-based warfarin therapy.
    Vir: Pharmacogenomics journal. - ISSN 1470-269X (Vol. 5, no. 3, 2005, str. 193-202)
    Vrsta gradiva - članek, sestavni del
    Leto - 2005
    Jezik - angleški
    COBISS.SI-ID - 1729649

vir: Pharmacogenomics journal. - ISSN 1470-269X (Vol. 5, no. 3, 2005, str. 193-202)
loading ...
loading ...
loading ...